PtCl2- and PtCl4-Catalyzed Cycloisomerization of Polyunsaturated Precursors
FULL PAPER
10.5, 1.5 Hz, 1 H), 3.32 (s, 3 H, OMe), 2.52 (s, 1 H), 2.07 (m, 2 H),
1.76 (m, 2 H), 1.69 (m, 2 H), 1.50–1.30 (m, 4 H), 1.18 (s, 3 H,
CH3), 1.17 (s, 3 H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ
OMe), 2.47 (m, 2 H), 1.75 (s, 2 H), 1.12 (s, 3 H), 1.10 (s, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 153.7 (C), 148.6 (CH), 132.2
(CH), 119.1 (CH2, CH=CH2), 109.8 (CH2, CH=CH2), 87.9 (C),
= 149.6 (CH), 139.3 (CH), 114.7 (CH2, CH=CH2), 109.6 (CH2, 80.3 (C), 75.3 (C), 52.7 (CH3), 51.5 (CH3, OMe), 49.5 (CH2), 43.8
CH=CH2), 85.1 (C), 76.3 (C), 76.2 (CH), 51.2 (CH3, OMe), 49.7
(CH2), 40.1 (CH2), 37.0 (C), 34.1 (CH2), 29.4 (CH2), 23.8 (CH2),
28.8 (CH3), 28.7 (CH3) ppm; 7aD (C16H25DO): 1H NMR
(400 MHz, CDCl3): the same spectrum as that of 7a, except no
signal at δ = 2.52 ppm. 13C NMR (100 MHz, CDCl3): the same
spectrum as that of 7a, except δ = 85.1 (t, J = 7 Hz) and 76.2 (t, J
= 39 Hz) ppm. CIMS: (NH3) m/z (%) = 253 (15) [M + NH4]+, 236
(21) [M + H]+, 221 [M – 15] +, 204 [M – 31] +.
(CH2), 36.6 (C), 28.6 (CH3), 27.9 (CH3) ppm.
1-Allyl-1-ethynyl-3,3-dimethylpent-4-enyl 4Ј-Nitrobenzoate (1g): IR
(neat): ν = 3300, 3080, 2960, 2115, 1730, 1640, 1610, 1530, 1350
˜
1
cm–1. H NMR (200 MHz, CDCl3): δ = 8.29 (d, J = 9.0 Hz, 2 H,
Ar), 8.16 (d, J = 9.0 Hz, 2 H, Ar), 6.00 (dd, J = 17.4, 10.6 Hz, 1
H), 5.92 (m, 1 H), 5.18 (d, J = 16.2 Hz, 1 H trans), 5.16 (d, J =
11.2 Hz, 1 H cis), 4.95 (dd, J = 17.4, 1.0 Hz, 1 H trans), 4.84 (dd,
J = 10.6, 1.0 Hz, 1 H cis), 3.07 (dd, J = 14.0, 7.2 Hz, 1 H), 2.90
(dd, J = 14.0, 7.2 Hz, 1 H), 2.76 (s, 1 H), 2.40 (d, J = 15.0 Hz, 1
H), 2.11 (d, J = 15.0 Hz, 1 H), 1.23 (s, 3 H, CH3), 1.20 (s, 3 H,
CH3) ppm. 13C NMR (50 MHz, CDCl3): δ = 163.0 (C, C=O), 148.4
5-Ethynyl-5-methoxy-7,7-dimethylundeca-1,10-diene (7b): IR (neat):
ν = 3300, 3070, 2940, 2100, 1640, 1460, 1075 cm–1. 1H NMR
˜
(400 MHz, CDCl3): δ = 5.81 (m, 2 H), 5.02 (d, J = 17.3 Hz, 1 H),
4.98 (d, J = 17.7 Hz, 1 H), 4.95 (d, J = 11.5 Hz, 1 H), 4.89 (d, J = (CH), 136.5 (C, Ar), 132.0 (CH), 130.8 (2 CH, Ar), 128.5 (C, Ar),
10.2 Hz, 1 H), 3.29 (s, 3 H, OMe), 2.53 (s, 1 H), 2.15 (m, 2 H),
2.02 (m, 2 H), 1.76 (m, 2 H), 1.65 (d, J = 14.2 Hz, 1 H), 1.59 (d, J
= 14.2 Hz), 1.44 (m, 2 H), 1.04 (s, 3 H), 1.03 (s, 3 H) ppm. 13C
123.6 (2 CH, Ar), 119.7 (CH2, CH=CH2), 110.4 (CH2, CH=CH2),
82.8 (C), 79.1 (C), 77.0 (CH), 49.2 (CH2), 44.8 (CH2), 36.9 (C),
29.0 (CH3), 28.0 (CH3) ppm. GCMS (EI): m/z (%) = 286 (9) [M–
NMR (100 MHz, CDCl3): δ = 139.8 (CH), 138.3 (CH), 114.5 (CH2, C3H5], 150 (100). C19H21NO4 (327.38): calcd. C 69.71, H 6.47, N
CH=CH2), 113.6 (CH2, CH=CH2), 84.4 (C), 76.2 (CH), 75.5 (C),
50.8 (CH3, OMe), 48.1 (CH2), 42.9 (2 CH2), 39.7 (CH2), 33.5 (C),
28.7 (CH2), 28.5 (CH3), 28.3 (CH3) ppm. C16H26O (234.38): calcd.
C 81.99, H 11.18; found C 81.84, H 11.35.
4.28; found C 69.65; H, 6.60; N, 4.18.
1-Allyl-1-ethynyl-3,3-dimethylpent-4-enyl Acetate (1h): IR (neat): ν
˜
= 3300, 3100, 2950, 2350, 1750, 1640, 1440, 1370 cm–1. H NMR
1
(200 MHz, CDCl3): δ = 5.93 (dd, J = 17.2, 10.3 Hz, 1 H), 5.81 (m,
1 H), 5.13–5.04 (m, 2 H), 4.90 (dd, J = 17.7, 1.5 Hz, 1 H trans),
4.86 (dd, J = 10.3, 1.5 Hz, 1 H cis), 2.87 (dd, J = 14.3, 7.4 Hz, 1
H), 2.69 (dd, J = 14.3, 7.4 Hz, 1 H), 2.60 (s, 1 H), 2.15 (d, J =
15.3 Hz, 1 H), 1.95 (s, 3 H, OAc), 1.86 (d, J = 15.3 Hz, 1 H), 1.15 (s,
3 H, CH3), 1.11 (s, 3 H, CH3) ppm. 13C NMR (50 MHz, CDCl3): δ
= 169.4 (C, C=O), 148.7 (CH), 132.3 (CH), 119.1 (CH2, CH=CH2),
5-Methoxy-3,3,5-trimethylhept-1-en-6-yne (7c): IR (neat): ν = 3309,
˜
1
3083, 2923, 2854, 2109, 1639 cm–1. H NMR (400 MHz, CDCl3):
δ = 6.01 (dd, J = 17.7, 10.8 Hz, 1 H), 4.92 (dd, J = 17.7, 1.3 Hz, 1
H), 4.87 (dd, J = 10.8, 1.3 Hz, 1 H), 3.33 (s, 3 H, OMe), 2.48 (s, 1
H), 1.83 (d, J = 14.6 Hz, 1 H), 1.76 (d, J = 14.6 Hz, 1 H), 1.42 (s,
3 H), 1.16 (s, 3 H), 1.14 (s, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 149.6 (CH), 109.7 (CH2, CH=CH2), 85.8 (C), 74.9 109.7 (CH2, CH=CH2), 83.5 (C), 77.0 (C), 75.9 (CH), 49.1 (CH2),
(CH), 73.4 (C), 52.7 (CH2), 51.2 (CH3, OMe), 37.0 (C), 28.9 (CH3), 44.6 (CH2), 36.8 (C), 28.9 (CH3), 27.7 (CH3), 22.2 (CH3, OAc)
28.4 (CH3), 28.0 (CH3) ppm.
ppm.
5-Ethynyl-5-methoxy-non-1-ene (7d): IR (neat): ν = 3310, 3078,
1-Methallyl-1-ethynyl-3,3-dimethylpent-4-enyl 4Ј-Nitrobenzoate (1i):
˜
2926, 2856, 1642 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.84 (ddt,
J = 17.4, 10.4, 6.6 Hz, 1 H), 5.05 (dd, J = 17.4, 1.5 Hz, 1 H), 4.96
(dd, J = 10.4, 1.5 Hz, 1 H), 3.33 (s, 3 H, OMe), 2.46 (s, 1 H), 2.17
(m, 2 H), 1.75 (t, J = 8.4 Hz, 2 H), 1.67 (t, J = 7.8 Hz, 2 H), 1.43–
1.30 (m, 4 H), 0.92 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 138.3 (CH), 114.5 (CH2, CH=CH2), 77.2 (CH), 76.1
IR (neat): ν = 3300, 3080, 2960, 2115, 1730, 1640, 1610, 1530, 1350
˜
1
cm–1. H NMR (200 MHz, CDCl3): δ = 8.29 (d, J = 9.2 Hz, 2 H,
Ar), 8.18 (d, J = 9.2 Hz, 2 H, Ar), 6.02 (dd, J = 17.4, 10.6 Hz, 1
H), 4.97 (dd, J = 10.6, 1.0 Hz, 1 H cis), 4.86 (d, J = 1.2 Hz, 2 H),
4.85 (dd, J = 17.4, 1.0 Hz, 1 H trans), 3.06 (d, J = 14.4 Hz, 1 H),
2.87 (d, J = 14.4 Hz, 1 H), 2.77 (s, 1 H), 2.42 (d, J = 15.0 Hz, 1
(C), 74.1 (C), 51.2 (CH3, OMe), 37.5 (CH2), 36.9 (CH2), 28.1 H), 2.11 (d, J = 15.0 Hz, 1 H), 1.82 (s, 3 H, CH3), 1.24 (s, 3 H,
(CH2), 25.9 (CH2), 22.9 (CH2), 14.0 (CH3) ppm.
CH3), 1.20 (s, 3 H, CH3) ppm. 13C NMR (50 MHz, CDCl3): δ =
163.1 (C, C=O), 148.5 (CH), 140.2 (C), 136.6 (C, Ar), 130.8 (2
CH+C, Ar), 126.6 (2 CH, Ar), 116.7 (CH2, CH=CH2), 110.3 (CH2,
CH=CH2), 83.1 (C), 79.0 (C), 77.5 (CH), 49.8 (CH2), 48.2 (CH2),
36.9 (C), 29.2 (CH3), 27.9 (CH3), 24.1 (CH3) ppm. GCMS (EI):
m/z (%) = 286 (5) [M – C4H7], 150 (100).
(3-Allyl-3-methoxy-hept-6-en-1-ynyl)trimethylsilane (7e): IR (neat):
1
ν = 3078, 2956, 2928, 2856, 2165, 1642 cm–1. H NMR (400 MHz,
˜
CDCl3): δ = 5.83 (m, 2 H), 5.10 (m, 2 H), 5.05–4.93 (m, 2 H), 3.35
(s, 3 H), 2.45 (d, J = 7.4 Hz, 2 H), 2.18 (m, 2 H), 1.71 (t, J =
8.3 Hz, 2 H), 0.18 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ
= 138.8 (CH), 133.5 (CH), 118.4 (CH2, CH=CH2), 114.8 (CH2,
CH=CH2), 105.8 (C), 91.8 (C), 76.4 (C), 51.8 (CH3, OMe), 42.6
(CH2), 37.5 (CH2), 28.6 (CH2), 0.30 (3 CH3, TMS) ppm.
1-Allyl-1-ethynylpent-4-enyl Acetate (1j): IR (neat): ν = 3295, 3079,
˜
2980, 2928, 2857, 2118, 1742, 1642 cm–1. 1H NMR (400 MHz,
CDCl3): δ = 5.84–5.76 (m, 2 H), 5.15–4.94 (m, 4 H), 2.79–2.75 (m,
2 H), 2.59 (s, 1 H), 2.23–2.21 (m, 2 H), 2.06–2.04 (m, 1 H), 2.00 (s,
3 H, OAc), 1.91–1.82 (m, 1 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 169.5 (C, C=O), 137.8 (CH), 132.1 (CH), 119.5 (CH2,
CH=CH2), 115.3 (CH2, CH=CH2), 82.8 (C), 78.2 (C), 75.0 (CH),
42.8 (CH2), 37.7 (CH2), 28.5 (CH2), 22.1 (CH3, OAc) ppm.
Methyl 4-Allyl-4-methoxy-6,6-dimethyloct-7-en-2-ynoate (7f): To a
solution of 1a (384 mg, 2 mmol, 1 equiv.) in dry THF (10 mL) was
added nBuLi (0.95 mL of a 2.2 solution, 2.1 mmol, 1.05 equiv.)
at –78 °C. Methyl chloroformate (0.46 mL, 6 mmol, 3 equiv.) was
added, and the mixture was allowed to warm to room temp. The
reaction was quenched with a saturated NH4Cl solution and ex-
tracted with Et2O. The combined organic layers were washed with
1-But-3-enyl-1-ethynyl-3,3-dimethylpent-4-enyl Acetate (21): IR
(neat): ν = 3306, 3081, 2965, 2931, 2873, 2117, 1743, 1642 cm–1.
˜
brine, dried with MgSO4 and concentrated to give 7f (495 mg, 99%
1H NMR (400 MHz, CDCl3): δ = 5.94 (dd, J = 17.4, 10.6 Hz, 1
H), 5.78 (m, 1 H), 5.04–4.86 (m, 4 H), 2.61 (s, 1 H), 2.23–2.17 (m,
yield). IR (neat): ν = 3081, 2955, 2873, 2230, 1717, 1639 cm–1. H
1
˜
NMR (400 MHz, CDCl3): δ = 5.94 (dd, J = 17.4, 10.6 Hz, 1 H), 4 H), 2.03 (m, 1 H), 1.99 (s, 3 H, OAc), 1.93–1.90 (m, 1 H), 1.16
5.78 (m, 1 H), 5.11 (m, 2 H), 4.90 (dd, J = 17.4, 1.3 Hz, 1 H), 4.84
(dd, J = 10.6, 1.3 Hz, 1 H), 3.76 (s, 3 H, CO2Me), 3.33 (s, 3 H,
(s, 3 H), 1.13 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
169.5 (C, C=O), 137.8 (CH), 132.1 (CH), 119.5 (CH2, CH=CH2),
Eur. J. Org. Chem. 2006, 4618–4633
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4627